The Clorox Company $CLX Shares Sold by Truist Financial Corp

Truist Financial Corp cut its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 21.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 27,259 shares of the company’s stock after selling 7,541 shares during the period. Truist Financial Corp’s holdings in Clorox were worth $3,361,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Stonegate Investment Group LLC lifted its stake in Clorox by 5.2% during the third quarter. Stonegate Investment Group LLC now owns 3,081 shares of the company’s stock worth $380,000 after purchasing an additional 152 shares in the last quarter. Triton Financial Group Inc raised its holdings in shares of Clorox by 2.4% in the 3rd quarter. Triton Financial Group Inc now owns 7,413 shares of the company’s stock valued at $914,000 after buying an additional 173 shares during the period. CFS Investment Advisory Services LLC lifted its stake in Clorox by 5.7% during the 3rd quarter. CFS Investment Advisory Services LLC now owns 2,733 shares of the company’s stock worth $317,000 after acquiring an additional 148 shares in the last quarter. Vanguard Personalized Indexing Management LLC boosted its holdings in Clorox by 64.2% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock valued at $3,173,000 after acquiring an additional 10,065 shares during the period. Finally, Cullen Frost Bankers Inc. grew its position in Clorox by 1.3% in the 3rd quarter. Cullen Frost Bankers Inc. now owns 54,526 shares of the company’s stock valued at $6,723,000 after acquiring an additional 693 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

Insider Transactions at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction on Friday, November 21st. The shares were bought at an average price of $104.13 per share, with a total value of $416,520.00. Following the completion of the transaction, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. This represents a 44.44% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.63% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have recently commented on CLX. Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. JPMorgan Chase & Co. boosted their target price on Clorox from $114.00 to $117.00 and gave the stock a “neutral” rating in a research note on Wednesday. Evercore ISI cut their price target on Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a report on Wednesday. TD Cowen lifted their price objective on Clorox from $108.00 to $111.00 and gave the company a “hold” rating in a research note on Wednesday. Finally, Barclays restated an “underweight” rating and set a $109.00 target price on shares of Clorox in a research note on Friday, January 16th. One equities research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $117.93.

View Our Latest Stock Report on Clorox

Clorox Price Performance

CLX stock opened at $117.59 on Friday. The business has a 50 day moving average price of $105.58 and a 200 day moving average price of $114.01. The company has a quick ratio of 0.50, a current ratio of 0.74 and a debt-to-equity ratio of 71.03. The stock has a market cap of $14.22 billion, a price-to-earnings ratio of 19.21, a PEG ratio of 0.57 and a beta of 0.59. The Clorox Company has a fifty-two week low of $96.66 and a fifty-two week high of $159.04.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the business posted $1.55 EPS. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. Equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be given a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.2%. Clorox’s dividend payout ratio is 81.05%.

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.